Brandywine Global Investment Management LLC Has $8.15 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Brandywine Global Investment Management LLC lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 109,889 shares of the company’s stock after selling 4,614 shares during the period. Brandywine Global Investment Management LLC owned 0.08% of Henry Schein worth $8,153,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in HSIC. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Henry Schein by 4.3% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,566 shares of the company’s stock valued at $316,000 after acquiring an additional 187 shares during the period. Rockefeller Capital Management L.P. grew its position in shares of Henry Schein by 27.3% during the 1st quarter. Rockefeller Capital Management L.P. now owns 4,520 shares of the company’s stock worth $312,000 after buying an additional 970 shares during the period. Teacher Retirement System of Texas grew its position in shares of Henry Schein by 23.0% during the 1st quarter. Teacher Retirement System of Texas now owns 15,655 shares of the company’s stock worth $1,084,000 after buying an additional 2,925 shares during the period. UBS Group AG grew its position in shares of Henry Schein by 280.7% during the 1st quarter. UBS Group AG now owns 116,208 shares of the company’s stock worth $8,046,000 after buying an additional 85,686 shares during the period. Finally, E Fund Management Co. Ltd. acquired a new position in shares of Henry Schein during the 1st quarter worth about $115,000. Institutional investors own 93.16% of the company’s stock.

HSIC stock opened at $77.72 on Thursday. The company has a current ratio of 1.79, a quick ratio of 0.98 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $10.86 billion, a PE ratio of 18.29, a PEG ratio of 1.32 and a beta of 0.88. Henry Schein, Inc. has a 1-year low of $59.44 and a 1-year high of $83.45. The business’s 50 day simple moving average is $77.20 and its 200 day simple moving average is $76.15.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 3rd. The company reported $1.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.13. Henry Schein had a return on equity of 15.86% and a net margin of 5.09%. The business had revenue of $2.97 billion for the quarter, compared to analyst estimates of $2.87 billion. Henry Schein’s revenue was up 76.2% compared to the same quarter last year. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.21 EPS for the current fiscal year.

Several equities analysts have recently weighed in on the company. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating and set a $82.00 price objective on the stock. in a report on Tuesday, October 5th. Barrington Research boosted their target price on Henry Schein from $91.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 4th. Finally, Piper Sandler boosted their target price on Henry Schein from $89.00 to $95.00 and gave the company an “overweight” rating in a research note on Tuesday, August 3rd. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Henry Schein has a consensus rating of “Buy” and a consensus target price of $90.50.

Henry Schein Profile

Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

See Also: What is a conference call?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.